Search Results - "Marfil, Silvia"
-
1
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
Published in Scientific reports (28-01-2021)“…The protective effect of neutralizing antibodies in SARS-CoV-2 infected individuals is not yet well defined. To address this issue, we have analyzed the…”
Get full text
Journal Article -
2
Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients
Published in Scientific reports (30-08-2022)“…Limited data exists on SARS-CoV-2 sustained-response to vaccine in patients with rheumatic diseases. This study aims to evaluate neutralizing antibodies (nAB)…”
Get full text
Journal Article -
3
Physicochemical characterization of the recombinant lectin scytovirin and microbicidal activity of the SD1 domain produced in rice against HIV-1
Published in Plant cell reports (01-04-2022)“…Key message Rice-produced SD1 retains its physicochemical properties and provides efficient pre-exposure HIV-1 prophylaxis against infection in vitro…”
Get full text
Journal Article -
4
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors
Published in Molecular oncology (01-04-2023)“…Patients with solid tumors have been a risk group since the beginning of the SARS‐CoV‐2 pandemic due to more significant complications, hospitalizations or…”
Get full text
Journal Article -
5
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
Published in npj vaccines (06-04-2023)“…Antigen display on the surface of Virus-Like Particles (VLPs) improves immunogenicity compared to soluble proteins. We hypothesised that immune responses can…”
Get full text
Journal Article -
6
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain
Published in Viruses (16-12-2021)“…Several cases of naturally infected dogs with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported despite the apparently low…”
Get full text
Journal Article -
7
The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis
Published in Frontiers in microbiology (24-03-2022)“…The understanding of HIV-1 pathogenesis and clinical progression is incomplete due to the variable contribution of host, immune, and viral factors. The…”
Get full text
Journal Article -
8
HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic
Published in Scientific reports (03-04-2019)“…In untreated HIV-1-infected individuals, viremia is positively associated with disease progression. However, some viremic non progressors (VNPs) individuals…”
Get full text
Journal Article -
9
Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals
Published in Frontiers in immunology (28-04-2022)“…Evidence on the determinants of the magnitude of humoral responses and neutralizing titers in individuals with mild COVID-19 is scarce. In this cohort study of…”
Get full text
Journal Article -
10
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
Published in Viruses (12-06-2021)“…With the spread of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a need to assess the protection conferred by both…”
Get full text
Journal Article -
11
Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides
Published in Frontiers in cellular and infection microbiology (06-11-2024)“…Extracellular vesicles (EVs) released by virus-infected cells have the potential to encapsulate viral peptides, a characteristic that could facilitate vaccine…”
Get full text
Journal Article -
12
Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration
Published in Clinical medicine insights. Blood disorders (01-01-2023)“…Vaccines are an important tool in combating the COVID-19 pandemic. Two mRNA vaccines (mRNA-1273 and BNT-162b2) and an adenovirus vector vaccine (Ad26.COV2.S)…”
Get full text
Journal Article -
13
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals
Published in iScience (18-11-2022)“…Mass vaccination campaigns reduced COVID-19 incidence and severity. Here, we evaluated the immune responses developed in SARS-CoV-2-uninfected patients with…”
Get full text
Journal Article -
14
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization
Published in iScience (21-04-2023)“…The elicitation of cross-variant neutralizing antibodies against SARS-CoV-2 represents a major goal for current COVID-19 vaccine strategies. Additionally,…”
Get full text
Journal Article -
15
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
Published in iScience (21-07-2023)“…SARS-CoV-2 emerged in December 2019 and quickly spread worldwide, continuously striking with an unpredictable evolution. Despite the success in vaccine…”
Get full text
Journal Article -
16
Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals
Published in PloS one (02-12-2014)“…HIV-1 infection increases plasma levels of inflammatory markers. Combination antiretroviral therapy (cART) does not restore inflammatory markers to normal…”
Get full text
Journal Article -
17
Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression
Published in Biomedicines (01-09-2022)“…In the absence of antiviral therapy, HIV-1 infection progresses to a wide spectrum of clinical manifestations that are the result of an entangled contribution…”
Get full text
Journal Article -
18
Gp120/CD4 blocking antibodies are frequently elicited in ART-naïve chronically HIV-1 infected individuals
Published in PloS one (24-03-2015)“…Antibodies with the ability to block the interaction of HIV-1 envelope glycoprotein (Env) gp120 with CD4, including those overlapping the CD4 binding site…”
Get full text
Journal Article -
19
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression
Published in AIDS (London) (10-03-2000)“…To investigate the virological and immunological impact of a structured treatment interruption (STI) in a cohort of HIV-1 chronically infected patients with a…”
Get full text
Journal Article -
20
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen
Published in AIDS (London) (24-10-2006)“…To analyse the genetic changes in the gp41 protein in HIV-infected patients with detectable plasma viraemia receiving a long-term salvage enfuvirtide regimen…”
Get full text
Journal Article